Observational study to clarify the pathology of malignant tumors using cancer clinical sequence data and to evaluate the clinical value of cancer clinical sequence

Observational study to clarify the pathology of malignant tumors using cancer clinical sequence data and to evaluate the clinical value of cancer clinical sequence - Observational study for evaluation of basic and clinical value of cancer clinical sequence

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029764

Enrollment

1000

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent cancer clinical sequence examination

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: subjects who obtained document agreement with the free will of the subjects themselves or substitute persons with sufficient understanding, after receiving sufficient explanation for participation in this research

Exclusion criteria

Exclusion criteria: Patients who are judged inappropriate as the subject by the research director

Design outcomes

Primary

Measure	Time frame
Prognosis of patients who underwent cancer clinical sequence	—

Secondary

Measure	Time frame
Whether the cancer clinical sequence had influence on patient's treatment choice	—

Countries

Japan

Contacts

Public ContactShunsuke Kato

Juntendo Univ Hospital Dept Oncology

katoshun@juntendo.ac.jp03-3813-3111

Outcome results